PenIpamorelin 10 mg
A selective GHRP studied for growth-hormone release and recovery research.
CJC-1295 PENMetabolic · GHRH
A synthetic growth-hormone-releasing hormone (GHRH) analog studied for stimulating endogenous GH release and elevating IGF-1 across body-composition research models.
Available to verified researchers. Pricing and the batch Certificate of Analysis are shared on request.
CJC-1295 is a GHRH analog studied for stimulating pulsatile growth-hormone release and raising IGF-1, frequently paired with a GHRP such as Ipamorelin in GH-axis research models.
Features
CJC-1295 is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.
Handling & compliance
This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human or veterinary use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.
PenA selective GHRP studied for growth-hormone release and recovery research.
PenA growth-peptide research blend studied for the GH/IGF-1 axis and recovery endpoints.
PenThe 10 mg GHRH-analog pen for GH-axis and visceral-fat research.
Request a researcher account to view the Certificate of Analysis for this lot and place an order with the lab.